Literature DB >> 26252120

Blockbuster expectations for hepatitis B therapeutic vaccine.

Suzanne Elvidge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26252120     DOI： 10.1038/nbt0815-789

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study.

Authors:  Anuj Gaggar; Claire Coeshott; David Apelian; Timothy Rodell; Brian R Armstrong; Gong Shen; G Mani Subramanian; John G McHutchison
Journal:  Vaccine       Date:  2014-07-18       Impact factor: 3.641

2.  Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver.

Authors:  N Obeng-Adjei; D K Choo; J Saini; J Yan; P Pankhong; A Parikh; J S Chu; D B Weiner
Journal:  Cancer Gene Ther       Date:  2012-10-05       Impact factor: 5.987
  2 in total
  4 in total

1.  Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination.

Authors:  Danming Zhu; Longchao Liu; Dan Yang; Sherry Fu; Yingjie Bian; Zhichen Sun; Junming He; Lishan Su; Liguo Zhang; Hua Peng; Yang-Xin Fu
Journal:  J Immunol       Date:  2016-03-02       Impact factor: 5.422

Review 2.  Future Therapy for Hepatitis B Virus: Role of Immunomodulators.

Authors:  Edward A Pham; Ryan B Perumpail; Benjamin J Fram; Jeffrey S Glenn; Aijaz Ahmed; Robert G Gish
Journal:  Curr Hepatol Rep       Date:  2016-11-10

3.  Hepitopes: A live interactive database of HLA class I epitopes in hepatitis B virus.

Authors:  Sheila Lumley; Howard Noble; Martin J Hadley; Liz Callow; Amna Malik; Yi Yi Chua; Owen J Duffey; Natalia Grolmusova; Arvind Kumar; Samuel Ravenscroft; Jonathan I Spencer; Christoph Neumann-Haefelin; Robert Thimme; Monique Andersson; Paul Klenerman; Eleanor Barnes; Philippa C Matthews
Journal:  Wellcome Open Res       Date:  2016-11-15

Review 4.  Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?

Authors:  Ganesh Selvaraj Duraisamy; Dattatry Bhosale; Ivana Lipenská; Ivana Huvarova; Daniel Růžek; Marc P Windisch; Andrew D Miller
Journal:  Viruses       Date:  2020-09-07       Impact factor: 5.048
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.